Navigation Links
Stop & Shop Alerts Customers to Product Advisory by ConAgra Foods
Date:10/10/2007

Alert follows ConAgra Foods Advisory on Pot Pies containing Poultry

QUINCY, Mass., Oct. 10 /PRNewswire-USNewswire/ -- The Stop & Shop Supermarket Company LLC, following a product advisory by ConAgra Foods, announced it has removed from its shelves all ConAgra 7 oz. Banquet Pot Pies containing poultry because of possible Salmonella contamination. ConAgra announced the alert today.

As a precautionary measure, Stop & Shop immediately removed all production codes of ConAgra's 7 oz. Banquet Pot Pies containing poultry from its stores.

The products manufactured by ConAgra and carried by Stop & Shop and subject to the advisory are as follows:

Banquet 7oz. Vegetable Pot Pie with Turkey

UPC Code: 3100010103

Bearing the number P9 on the side of the package

Banquet 7oz. Vegetable Pot Pie with Chicken

UPC Code: 3100010101

Bearing the number P9 on the side of the package

Customers who purchased these products from Stop & Shop and still may have them should discard the product and return the packaging to any Stop & Shop for a full refund.

Consumption of food contaminated with salmonella, may cause serious and sometimes deadly infections in young children, the elderly and people with weakened immune systems. In otherwise healthy people, salmonellosis may cause short-term symptoms such as high fever, severe headache, vomiting, nausea, abdominal pain and diarrhea.

Customers with questions about the affected product may phone ConAgra at 1-866-484-8671. Customers may also phone Stop & Shop Customer Service at 1-800-767-7772 or visit Stop & Shop's website at http://www.stopandshop.com.

About Stop & Shop

The Stop & Shop Supermarket Company, based in Quincy, Massachusetts, employs more than 59,000 associates and operates 389 stores throughout Massachusetts, Connecticut, Rhode Island, Maine, New Hampshire, New York and New Jersey. Stop
'/>"/>

SOURCE The Stop & Shop Supermarket Company LLC
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Alerts for safety of heart device
2. New Alerts Needed for ADHD drugs
3. WHO Alerts Governments to Step Up Action to Curb AIDS
4. Probable Health Monitor Sends SMS of Emergency Alerts and ECG
5. Now, Dads to Get Text Alerts on How to Raise Their Children
6. Dialysis Clinics Owned By Fresenius Flourishes Due To Its Customers
7. Unsuspecting Customers Served With the Hepatitis A Virus?
8. Pesticide impairs male reproductive function
9. Look For Food Allergens On The Product Label.
10. Link between chlorine byproducts and pregnancy risks
11. Animal insulin product to be discontinued by drug major Eli Lilly
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2008)...-five day OnBase deployment critical in electronic...efit patients, CLEVELAND, July 9 /PRNewswire/ -- ...rise document management software suite, announced...sults since the deployment of,OnBase in March. Bas... four,states, SSM is a forward-thinking health car...
(Date:7/9/2008)...NTO, July 9 /PRNewswire-FirstCall/ - MDS Inc. (TSX...and services to the global life,sciences markets, ...f,Canada Limited (AECL) with notice of arbitration...el AECL to fulfill its contractual obligations,und... (ILTSA) and if not,granted, seeking significant m...
(Date:7/9/2008)... DRE, Inc., a premier internation...s its customers that as much as $250,000 in medica...come tax filings. , Louis...mulus Act of 2008, in accordance with Tax Code Sec...al equipment bought in 2008. This could make 2008 ...
(Date:7/9/2008)... InsuranceSpecialists.com, a lead...or almost a decade, now offers comprehensive infor...idential candidates are taking on health reform as...ment-free, supplies unbiased material on medical, ...elp consumers make the best choices in coverage fo...
Breaking Medicine News(10 mins):Health News:SSM Health Care Upgrades Patient Care With Speedy Document Management Implementation 2Health News:SSM Health Care Upgrades Patient Care With Speedy Document Management Implementation 3Health News:MDS Commences Arbitration against AECL over Cancelled MAPLE Project and Files $1.6 Billion Court Claim against AECL and the Government of Canada 2Health News:MDS Commences Arbitration against AECL over Cancelled MAPLE Project and Files $1.6 Billion Court Claim against AECL and the Government of Canada 3Health News:Economic Stimulus Act Can Improve Medical Equipment Purchasing Power 2Health News:InsuranceSpecialists.com Looks at the Candidates and Health Reform 2Health News:InsuranceSpecialists.com Looks at the Candidates and Health Reform 3
...cay has been developed by BASF, a German company, ...The company claims its// product can reduce the am... The product was developed in collaboration with ... The gum helps in fighting tooth decay by prevent...
...s and soft drinks in hospitals, schools and other ...betes and obesity. Australia// has the world's fa...is strongly linked with type-2 diabetes. In an ar... Journal of Australia, Paul Zimmet, Director of th...
...eens' attitudes that covers an overall picture of ...immoral practices, one// third of the American tee...gal drugs were used while their parents were at ho...e aware of what was happening when teenagers parti...
... breast cancer test, which could save several wome...ady, doctors have been using core needle biopsy to...ination. This new test involves the study of gen...s may help in detecting more aggressive cancers th...
Other Medicine News:Health News:Parents ignorant about kids' immoral practices 2Health News:Novel test for diagnosis of breast cancer 2
(Date:7/6/2008)...rketing Authorization Application currently ...E, July 7 /- Cell Therapeut...ced the publication of results from its,randomized...poliglumex,CT-2103) with gemcitabine or vinorelbi...) patients with previously untreated non-small cel...
(Date:7/3/2008)...ewswire-USNewswire/ -- All newborn infants,should ...esent at birth,according to a new recommendation ...recommendation and the accompanying summary of evi...Children whose hearing is impaired at birth, durin...with verbal and nonverbal communication and,social...
(Date:7/3/2008)...MBRIDGE Massachusetts, July 3,/PRNewswire-FirstCal...ology company, Jerini AG for an equity purchase p...a (HAE) product, FIRAZYR(R), to its Human Genetic... global sales expected to be around $350-400 mill...ve environment, - Expected to be accretive for No...
(Date:7/2/2008)...y Endpoint Met in Stage 1 of Two-Stage Study ...ble Patients to Date Continue to Show Objective Tu...e -, TUSTIN, Calif., July 2 /PRNewswire-FirstCall...M ) today reported that its lead product,candidate...imary endpoint,in its ongoing Phase II clinical tr...
Breaking Medicine Technology:Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 2Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 3Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 4Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 5Task Force Recommends Screening for Hearing Loss in All Newborns 2Task Force Recommends Screening for Hearing Loss in All Newborns 3Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 2Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 3Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 4Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 5Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 6Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 7Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 8Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer 2Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer 3Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer 4CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation 139 1CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation 139 2CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation 139 3International study strengthens case for daily calcium pill 195 1International study strengthens case for daily calcium pill 195 2Methamphetamine study suggests increased risk for HIV transmission 192 1Methamphetamine study suggests increased risk for HIV transmission 192 2Embryonic Stem Cells Repair Human Heart 190 1Embryonic Stem Cells Repair Human Heart 190 2Embryonic Stem Cells Repair Human Heart 190 3
...Presented at Society of Nuclear,Medicine Annual Me...stCall/ --,Immunomedics, Inc. , a biopharmaceutica...ies to treat cancer and other serious,diseases, to...en,(CEA) antibody, labetuzumab, labeled with the r...active when given in two doses,to patients with co...
...omide in Multiple Myeloma,Presented at the America..., CHICAGO, June 04, 2007 /PRNewswire-FirstCall/ --...ults of a Phase III study,demonstrating that the a...s overall survival (OS) by 17.6 months in patients...eloma compared to the,current standard of care. Th...
Other Medicine Technology:Repeated Radioimmunotherapy With 131I-Labetuzumab Appears Safe and,Effective in Colorectal Cancer with Liver Metastases 2Repeated Radioimmunotherapy With 131I-Labetuzumab Appears Safe and,Effective in Colorectal Cancer with Liver Metastases 3Repeated Radioimmunotherapy With 131I-Labetuzumab Appears Safe and,Effective in Colorectal Cancer with Liver Metastases 4Repeated Radioimmunotherapy With 131I-Labetuzumab Appears Safe and,Effective in Colorectal Cancer with Liver Metastases 5Adding Thalidomide to Standard Therapy Improves Survival in Newly,Diagnosed Multiple Myeloma Patients Over Age 75 2Adding Thalidomide to Standard Therapy Improves Survival in Newly,Diagnosed Multiple Myeloma Patients Over Age 75 3Adding Thalidomide to Standard Therapy Improves Survival in Newly,Diagnosed Multiple Myeloma Patients Over Age 75 4Adding Thalidomide to Standard Therapy Improves Survival in Newly,Diagnosed Multiple Myeloma Patients Over Age 75 5Adding Thalidomide to Standard Therapy Improves Survival in Newly,Diagnosed Multiple Myeloma Patients Over Age 75 6
The ProtecPoint Exit Alerting System, instantly help protect individuals (e.g. patients, staff) and assets (e.g. medical equipment), with easily-mountable exit controllers placed throughout your faci
...nt of controlled substances, critical supplies, or...vess" are designed to perform this function. Conti...ervention. Radio frequency identification (RFID) t...lf™ product solutions incorporate custom desi...
Agility can facilitate bed and room management through business process optimization using RFID technology. Bed and room management may be integrated with other AgileTrac products.
Assetrac allows identification, location, and protection of your assets.
Medicine Products: